GeNeuro SA Employee Directory
Biotechnology ResearchSwitzerland11-50 Employees
GeNeuro SA is a biotechnology research company based in Switzerland focused on developing treatments for inflammatory and neurodegenerative disorders linked to Human Endogenous Retroviruses (HERVs). Its work targets conditions such as multiple sclerosis, amyotrophic lateral sclerosis, and long COVID, with efforts aimed at slowing disability progression and addressing cognitive impairment and fatigue in affected individuals. The company operates within the biopharmaceutical field, seeking to translate insights about HERVs into therapeutic candidates and clinical programs. GeNeuro operates from its Geneva area presence and pursues its development through clinical-stage initiatives, including the advancement of anti-HERV–based antibodies and related therapeutic approaches. The organization collaborates in the broader research landscape to explore how modulating HERV-related pathways may impact neurodegenerative and autoimmune diseases, positioning itself as a specialized player within the neuroscience and immunology spaces.